Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma

[1]  A. Droit,et al.  Evaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy Samples , 2015, PloS one.

[2]  Berthold Lausen,et al.  Quantitative proteome profiling of lymph node‐positive vs. ‐negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis , 2014, International journal of cancer.

[3]  T. Kondo,et al.  Proteomic Profile of Epithelioid Sarcoma , 2014 .

[4]  C. Antonescu,et al.  Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material , 2014, Genes, chromosomes & cancer.

[5]  C. Fletcher,et al.  WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition , 2014, Pathology.

[6]  T. Yamashita,et al.  High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma , 2013, PloS one.

[7]  Lin Zhu,et al.  Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues. , 2013, International journal of oncology.

[8]  Zhiyuan Shen,et al.  BCCIP suppresses tumor initiation but is required for tumor progression. , 2013, Cancer research.

[9]  X. Ren,et al.  Trichloroethylene induces biphasic concentration-dependent changes in cell proliferation and the expression of SET-associated proteins in human hepatic L-02 cells. , 2013, Biomedical and environmental sciences : BES.

[10]  A. D. Dei Tos,et al.  SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ , 2013, Molecular Cancer Therapeutics.

[11]  E. Jung,et al.  Prognostic value of CAPZA1 overexpression in gastric cancer , 2013, International journal of oncology.

[12]  Ingo Ruczinski,et al.  Statistical inference from multiple iTRAQ experiments without using common reference standards. , 2013, Journal of proteome research.

[13]  Stefan Wiemann,et al.  Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration , 2011, BMC Biology.

[14]  P. Wright,et al.  Methods in Quantitative Proteomics: Setting iTRAQ on the Right Track , 2011 .

[15]  J. Hartwig,et al.  The filamins , 2011, Cell adhesion & migration.

[16]  Akhilesh Pandey,et al.  Screening for therapeutic targets of vorinostat by SILAC‐based proteomic analysis in human breast cancer cells , 2010, Proteomics.

[17]  S. Lim,et al.  Phenotyping of an in vitro model of ischemic penumbra by iTRAQ-based shotgun quantitative proteomics. , 2010, Journal of proteome research.

[18]  D. Calderwood,et al.  Filamins Regulate Cell Spreading and Initiation of Cell Migration , 2009, PloS one.

[19]  N. Araki,et al.  An Integrated Approach of Differential Mass Spectrometry and Gene Ontology Analysis Identified Novel Proteins Regulating Neuronal Differentiation and Survival* , 2009, Molecular & Cellular Proteomics.

[20]  D. Reisman,et al.  The SWI/SNF complex and cancer , 2009, Oncogene.

[21]  P. D. Dal Cin,et al.  Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma , 2009, The American journal of surgical pathology.

[22]  Y. Iwamoto,et al.  Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. , 2009, Human pathology.

[23]  D. Vignjevic,et al.  Reorganisation of the dendritic actin network during cancer cell migration and invasion. , 2008, Seminars in cancer biology.

[24]  Ishtiaq Rehman,et al.  iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. , 2008, Journal of proteome research.

[25]  Chan‐Wha Kim,et al.  Proteome of mesenchymal stem cells , 2007, Proteomics.

[26]  Eithne Costello,et al.  Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility , 2006, Gut.

[27]  Silvana Pilotti,et al.  SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. , 2005, Cancer research.

[28]  N. Seki,et al.  Aberrant expression of RAB1A in human tongue cancer , 2005, British Journal of Cancer.

[29]  R. Mansel,et al.  The role of the CD44/ezrin complex in cancer metastasis. , 2003, Critical reviews in oncology/hematology.

[30]  S. Hirohashi,et al.  Proximal-Type Epithelioid Sarcoma: A Clinicopathologic Study of 20 Cases , 2001, Modern Pathology.

[31]  B. Weissman,et al.  The BRG-1 Subunit of the SWI/SNF Complex Regulates CD44 Expression* , 2001, The Journal of Biological Chemistry.

[32]  Yuan Yuan,et al.  Inhibition of breast and brain cancer cell growth by BCCIPα, an evolutionarily conserved nuclear protein that interacts with BRCA2 , 2001, Oncogene.

[33]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[34]  M. Carlier,et al.  Control of Actin Dynamics in Cell Motility , 2022 .

[35]  L. Guillou,et al.  "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. , 1997, The American journal of surgical pathology.

[36]  J. Cooper,et al.  Actin organization, bristle morphology, and viability are affected by actin capping protein mutations in Drosophila , 1996, The Journal of cell biology.

[37]  M. Horisberger,et al.  Interferons, Mx genes, and resistance to influenza virus. , 1995, American journal of respiratory and critical care medicine.

[38]  H. Hochkeppel,et al.  IFN-αInduced Human 78 kD Protein: Purification and Homologies with the Mouse Mx Protein, Production of Monoclonal Antibodies, and Potentiation Effect of IFN-γ , 1987 .

[39]  F. Enzinger,et al.  Epithelioid sarcoma: Diagnosis, prognostic indicators, and treatment *' † , 1985, The American journal of surgical pathology.

[40]  F. Collin,et al.  A Clinicopathologic and Immunohistochemical Analysis of 106 Cases From the French Sarcoma Group , 2009 .

[41]  D. Sept,et al.  New insights into mechanism and regulation of actin capping protein. , 2008, International review of cell and molecular biology.

[42]  S. Zigmond.  Beginning and ending an actin filament: control at the barbed end. , 2004, Current topics in developmental biology.

[43]  H. Hochkeppel,et al.  IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma. , 1987, Journal of interferon research.